SCHEMBL862107

SCHEMBL862107

COc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](OC)C2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 4/20 0.59
▸ MMP14 P50281 3/20 0.59
▸ ELAVL3 Q14576 2/20 0.58
▸ BACE1 P56817 6/20 0.55
▸ KDM4E B2RXH2 5/20 0.55
▸ PKM P14618 4/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ HSD17B10 Q99714 3/20 0.55
▸ MAPT P10636 3/20 0.55
▸ RECQL P46063 3/20 0.55
▸ GAA P10253 3/20 0.55
▸ SNCA P37840 3/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ APEX1 P27695 2/20 0.55
▸ APP P05067 2/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ RAD52 P43351 2/20 0.55
▸ ALOX15 P16050 2/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3805652 0.91 CYP3A4 (0.59) MMP2MMP14CYP3A4MAPK1
Meciadanol SCHEMBL29929029 0.90 BACE1 (0.68) MMP2MMP14ELAVL3BACE1KDM4E
Meciadanol SCHEMBL30049526 0.90 BACE1 (0.68) MMP2MMP14ELAVL3BACE1KDM4E
Meciadanol SCHEMBL862417 0.90 BACE1 (0.68) MMP2MMP14ELAVL3BACE1KDM4E
Meciadanol SCHEMBL13784973 0.90 BACE1 (0.68) MMP2MMP14ELAVL3BACE1KDM4E
Meciadanol SCHEMBL790769 0.90 BACE1 (0.68) MMP2MMP14ELAVL3BACE1KDM4E
Meciadanol SCHEMBL790768 0.90 BACE1 (0.68) MMP2MMP14ELAVL3BACE1KDM4E
Meciadanol SCHEMBL29929253 0.90 BACE1 (0.68) MMP2MMP14ELAVL3BACE1KDM4E
SCHEMBL13099975 0.86 KDM4E (0.74) BACE1KDM4EPKMMEN1KMT2A
SCHEMBL862094 0.86 KDM4E (0.74) BACE1KDM4EPKMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143308-B2 Synthesis of oligo/poly(catechins) and methods of use UNIVERSITY OF MASSACHUSETTS LOWELL (US) 2012-03-27 — — US disclosed
US-20090170928-A1 Synthesis of oligo/poly(catechins) and methods of use GOVERNMENT OF THE UNITED STATES 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170928-A1 Synthesis of oligo/poly(catechins) and methods of use POLI, PUF60, FABP3 MMP2 254/4885MMP14 52/4885ELAVL3 3132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback